A REVIEW ON BIOLOGICAL ACTIVITY OF 1, 3-DIAZOLE DERIVATIVES
DOI:
https://doi.org/10.22159/ijcpr.2022v14i5.2030Keywords:
1, 3-diazole, Anti-inflammatory, Anticancer, Antimicrobial, Analgesic, Anti-tubercular, Heterocyclic, Biological activeAbstract
1,3-diazole is also known as imidazole.1, 3-diazole is amphoteric in nature i.e. it shows both acidic and basic properties 1, 3-diazole is a five-member heterocyclic aromatic compound that possesses two nitrogen, three carbon, four hydrogen atom and two double bond. It has two nitrogen atom are present; both nitrogen atom are sp2 hybridized. It contains two nitrogen atoms, in which one nitrogen bear a hydrogen atom, and the other is called pyrrole type nitrogen. The derivatives of 1,3-diazole show different biological activities such as. Anti-inflammatory, antimicrobial, analgesic and anti-tubercular activities, etc. as reported in the literature. There are different examples of commercially available drugs in the market which contains a 1,3-diazole ring, such as Miconazole, Clotrimazole, Econazole, Enilconazole, Sulconazole etc This present review summarized some pharmacological activities and various kinds of synthetic routes for 1, 3-diazoleand their derived products.
Downloads
References
DA Williams, TL Lemke. Foye’s principle of medicinal chemistry. Vol. 5. Lippincott Williams & Wilkins; 2002. p. 36.
Singh H, Kapoor VK. Medicinal and pharmaceutical Chemistry, Vallabh Prakashan; 2008;2:1-2.
Boiani M, Gonzalez M. Imidazole and benzimidazole derivatives as chemotherapeutic agents. Mini Rev Med Chem. 2005;5(4):409-24. doi: 10.2174/1389557053544047, PMID 15853629.
Dhainaut A, Tizot A, Raimbaud E, Lockhart B, Lestage P, Goldstein S. Synthesis, structure, and neuroprotective properties of novel imidazolyl nitrones. J Med Chem. 2000;43(11):2165-75. doi: 10.1021/jm991154w, PMID 10841795.
Peng XM, Cai GX, Zhou CH. Recent developments in azole compounds as antibacterial and antifungal agents. Curr Top Med Chem. 2013;13(16):1963-2010. doi: 10.2174/ 15680266113139990125, PMID 23895097.
Pianalto KM, Alspaugh JA. New horizons in antifungal therapy. J Fungi (Basel). 2016;2(4):26. doi: 10.3390/jof2040026, PMID 29376943.
Carmona EM, Limper AH. Overview of treatment approaches for fungal infections. Clinics in Chest Medicine. 2017;38(3):393-402. doi: 10.1016/j.ccm.2017.04.003.
Lafleur MD, Sun L, Lister I, Keating J, Nantel A, long L, Ghannoum M, North J, Lee R E, Coleman K. Potentiation of azole antifungal by 2-adamantanamine. antimicrob. Agent Chemother 2013;57:3585-91.
Lloyd DH. Alternatives to conventional antimicrobial drugs: a review of future prospects. Vet Dermatol. 2012;23(4):299-304. doi: 10.1111/j.1365-3164.2012.01042.x, PMID 22409347.
Wang XL, Zhou CH, Geng RX. Advance in the research of antimicrobial drugs with sulfamide group. Chin J New Drugs. 2010;19:2050-9.
Tuncbilek M, Kiper T, Altanlar N. Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA. Eur J Med Chem. 2009;44(3):1024-33. doi: 10.1016/j.ejmech.2008.06.026, PMID 18718694.
Sharma S, Gangal S, Rauf A. Convenient one-pot synthesis of novel 2-substituted benzimidazoles, tetrahydrobenzimidazoles and imidazoles and evaluation of their in vitro antibacterial and antifungal activities. Eur J Med Chem. 2009;44(4):1751-7. doi: 10.1016/j.ejmech.2008.03.026, PMID 18472189.
Khan ZK, Jain P. Antifungal agents and immunomodulators in systemic mycoses. Indian J Chest Dis Allied Sci. 2000;42(4):345-55. PMID 15597684.
Rani N, Sharma A, Gupta GK, Singh R. Imidazoles as potential antifungal agents: a review. Mini Rev Med Chem. 2013;13(11):1626-55. doi: 10.2174/13895575113139990069, PMID 23815583.
Dhainaut A, Tizot A, Raimbaud E, Lockhart B, Lestage P, Goldstein S. Synthesis, structure, and neuroprotective properties of novel imidazolyl nitrones. J Med Chem. 2000;43(11):2165-75. doi: 10.1021/jm991154w, PMID 10841795.
Sharma D, Narasimhan B, Kumar P, Jalbout A. Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones. Eur J Med Chem. 2009;44(3):1119-27. doi: 10.1016/j.ejmech.2008.06.009, PMID 18657885.
Published
How to Cite
Issue
Section
Copyright (c) 2022 WAGHMARE SWEETI MOHAN, BARVE KOMAL B., RUCHAKE NIKITA K.
This work is licensed under a Creative Commons Attribution 4.0 International License.
